Innoviva Q3 EPS $0.98, Sales $67.26M Miss $75.65M Estimate
Portfolio Pulse from Benzinga Newsdesk
Innoviva reported Q3 earnings of $0.98 per share, beating the analyst consensus estimate of $0.27 by 262.96 percent. However, this is a 65 percent decrease from last year's earnings. The company's quarterly sales of $67.26 million missed the analyst consensus estimate of $75.65 million by 11.09 percent, but remained the same as last year's sales.
November 01, 2023 | 9:40 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Innoviva's Q3 earnings exceeded analyst expectations but are down from last year. Sales missed estimates but are consistent with last year.
Innoviva's earnings beat analyst expectations, which could have a positive impact on the stock. However, the decrease in earnings from last year and the missed sales estimates could offset this positive impact, leading to a neutral short-term impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100